HK Stock Market Move | REFIRE (02570) fell nearly 9% to reach a new historical low, with a total market value of less than 5 billion Hong Kong dollars. The recent rights issue raised a net amount of 2.58 billion Hong Kong dollars.
Reshape Energy (02570) fell nearly 9% in the afternoon, hitting a low of HK$48.06, a historic low. As of the time of writing, it has dropped by 8.67% to HK$48.22, with a trading volume of HK$54.84 million and a total market value of less than HK$5 billion.
REFIRE (02570) fell nearly 9% in the afternoon session, hitting a low of HK$48.06, a historical low. As of the time of writing, it fell 8.67% to HK$48.22, with a turnover of HK$54,848,000 and a total market value of less than HK$5 billion.
On the news front, REFIRE recently announced the completion of a private placement of a total of 4,536,000 shares, raising a net of HK$258 million. 50% of the funds are intended to be used for repaying bank loans and lease liabilities, with the remaining balance for general corporate purposes. Public information shows that REFIRE is a leading player in fuel cell technology. China International Capital Corporation (CICC) stated that fuel cell technology is experiencing rapid advancements in technology and cost reduction, and predicts that after 2028, the full life cycle cost of fuel cell heavy-duty vehicles is expected to gradually reach parity.
Related Articles

Sunflower Pharmaceutical Group (002737.SZ) has received acceptance for the registration application of the easy to live brand probiotic powder.

Zhejiang Gongdong Medical Technology (605369.SH) has obtained the Laboratory Accreditation Certificate from the China National Accreditation Service for Conformity Assessment (CNAS).

Bank of America Merrill Lynch: Maintains "buy" rating on HANG LUNG PPT (00101) with a target price of 10.4 Hong Kong dollars.
Sunflower Pharmaceutical Group (002737.SZ) has received acceptance for the registration application of the easy to live brand probiotic powder.

Zhejiang Gongdong Medical Technology (605369.SH) has obtained the Laboratory Accreditation Certificate from the China National Accreditation Service for Conformity Assessment (CNAS).

Bank of America Merrill Lynch: Maintains "buy" rating on HANG LUNG PPT (00101) with a target price of 10.4 Hong Kong dollars.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


